RVO
Showing 1 - 25 of 144
Central Retinal Vein Occlusion With Macular Edema, Branch Retinal Vein Occlusion With Macular Edema Trial in Taiwan (TLC399)
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Branch Retinal Vein Occlusion With Macular Edema
-
Chang Hua, Taiwan
- +5 more
Nov 24, 2021
Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)
Terminated
- Wet Age-related Macular Degeneration
- +2 more
-
Phoenix, Arizona
- +10 more
Nov 1, 2022
Retinal Vein Occlusion Trial in Groningen (Annexin A5)
Recruiting
- Retinal Vein Occlusion
- Annexin A5
-
Groningen, NetherlandsUMCG
Nov 11, 2021
Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)
Recruiting
- Retinal Vein Occlusion
- Aflibercept Ophthalmic
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Jan 5, 2022
Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))
Completed
- Retinal Vein Occlusion
- Macula Edema
- TLC399 (ProDex)
-
Phoenix, Arizona
- +19 more
Nov 24, 2021
Retinal Vein Occlusion, Diabetic Macular Edema, Branch Retinal Vein Occlusion Trial in Cleveland (Aflibercept)
Completed
- Retinal Vein Occlusion
- +3 more
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
May 10, 2021
Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)
Completed
- Diabetic Macular Edema
- Retina Vein Occlusion
-
Phoenix, Arizona
- +5 more
Nov 18, 2021
Macular Edema, Retinal Vein Occlusion Trial in United States (4 mg CLS-TA, Sham, IVT aflibercept)
Completed
- Macular Edema
- Retinal Vein Occlusion
- 4 mg CLS-TA
- +2 more
-
Phoenix, Arizona
- +13 more
Jan 18, 2021
Intravitreal Aflibercept in Diabetic Macular Edema and/or
Completed
- Macular Edema
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, China
- +10 more
Nov 10, 2022
Efficacy of RVO in Subjects Who Completed Parent Study
Completed
- Macular Edema
- Retinal Vein Occlusion
-
San Antonio, Texas(unnamed)
Dec 19, 2019
Macular Edema, Retinal Vein Occlusion Trial in Assiut (Intravitreal injection of Dexamethasone implant)
Recruiting
- Macular Edema
- Retinal Vein Occlusion
- Intravitreal injection of Dexamethasone implant
-
Assiut, EgyptFaculty of medicine
Feb 27, 2022
Wet Macular Degeneration, Age-related Macular Degeneration, Diabetic Macular Edema Trial in Philadelphia (Dorzolamide-timolol)
Completed
- Wet Macular Degeneration
- +3 more
-
Philadelphia, PennsylvaniaWills Eye Hospital / Mid Atlantic Retina
Dec 1, 2019
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Age Related Macular Degeneration, Diabetic Macular Edema, Macular Edema Trial in Toronto (Intravitreal ranibizumab)
Recruiting
- Age Related Macular Degeneration
- +3 more
- Intravitreal ranibizumab
-
Toronto, Ontario, Canada
- +1 more
Apr 27, 2021
Macular Edema, Retinal Vein Occlusion Trial in Damascus (suprachoroidal injection of Triamcinolone Acetonide.)
Completed
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal injection of Triamcinolone Acetonide.
-
Damascus, Syrian Arab RepublicAl Mouwasat University Hospital, Department of Ophthalmology
Aug 31, 2021
Diabetic Macular Oedema, Retinal Vein Occlusion With Macular Oedema Trial in Australia, New Zealand (IBE-814)
Recruiting
- Diabetic Macular Oedema
- Retinal Vein Occlusion With Macular Oedema
-
Strathfield, New South Wales, Australia
- +10 more
Jul 30, 2021
Branch Retinal Vein Occlusion Trial in Damietta (aflibercept (2mg/0.05ml))
Completed
- Branch Retinal Vein Occlusion
- aflibercept (2mg/0.05ml)
-
Damietta, EgyptAkram Fekry Elgazzar
Nov 22, 2023
Multiple Sclerosis Trial in Ostrava (Controlled combined exercise group, Conventional rehabilitation)
Recruiting
- Multiple Sclerosis
- Controlled combined exercise group
- Conventional rehabilitation
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Jan 3, 2023
Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Toronto (Intravitreal aflibercept)
Recruiting
- Age Related Macular Degeneration
- +3 more
- Intravitreal aflibercept
-
Toronto, Ontario, Canada
- +1 more
Apr 27, 2021
Fetuin A asPredictor of Deterioration of Renal Function in
Recruiting
- Arterial Hypertension
- No intervention.
-
Ostrava, Czech Republic, CzechiaUniversity Hospital Ostrava, - Department of Internal Medicine a
Jul 18, 2023
Eyelid Ptoses, Ectropion Eyelids, Entropion;Eye Trial in Ostrava (Vectra M3 imaging)
Recruiting
- Eyelid Ptoses
- +2 more
- Vectra M3 imaging
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Sep 8, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Saint Petersburg (Dextenza
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate
-
Saint Petersburg, FloridaRetina Vitreous Associates of Florida
Mar 10, 2021